Zomedica Pharmaceuticals Corp Stock Price on October 14, 2024
| ZOM Stock | USD 0.13 0.00 0.00% |
Below is the normalized historical share price chart for Zomedica Pharmaceuticals Corp extending back to July 29, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zomedica Pharmaceuticals stands at 0.13, as last reported on the 2nd of December, with the highest price reaching 0.13 and the lowest price hitting 0.13 during the day.
If you're considering investing in Zomedica Stock, it is important to understand the factors that can impact its price. As of now, Zomedica Stock is dangerous. Zomedica Pharmaceuticals shows Sharpe Ratio of 0.0199, which attests that the company had a 0.0199% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Zomedica Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check out Zomedica Pharmaceuticals' Market Risk Adjusted Performance of 0.2272, mean deviation of 1.91, and Downside Deviation of 7.8 to validate if the risk estimate we provide is consistent with the expected return of 0.0818%.
At this time, Zomedica Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 2nd of December 2024, Liabilities And Stockholders Equity is likely to grow to about 265.9 M, while Capital Stock is likely to drop about 243.6 M. . As of the 2nd of December 2024, Price To Sales Ratio is likely to drop to 7.40. In addition to that, Price Earnings Ratio is likely to drop to -5.97. Zomedica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of July 2016 | 200 Day MA 0.1396 | 50 Day MA 0.1271 | Beta 1.064 |
Zomedica |
Sharpe Ratio = 0.0199
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ZOM | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.12 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Zomedica Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zomedica Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.6184 | Enterprise Value Ebitda (7.19) | Price Sales 4.8252 | Shares Float 961.5 M | Wall Street Target Price 0.25 |
Zomedica Pharmaceuticals Main Headline on 14th of October 2024
Filed transaction by Zomedica Pharmaceuticals Corp Officer Cfo And Secretary. Grant, award or other acquisition pursuant to Rule 16b-3
Zomedica Pharmaceuticals Valuation on October 14, 2024
It is possible to determine the worth of Zomedica Pharmaceuticals on a given historical date. On October 14, 2024 Zomedica was worth 0.13 at the beginning of the trading date compared to the closed value of 0.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zomedica Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Zomedica Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zomedica Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zomedica Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.13 | 0.13 | 0.13 | 0.13 | 2,597,353 | |
10/14/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 3,222,287 |
| 0.13 | 0.13 | 0.12 | 0.12 | 5,851,089 |
| Backtest Zomedica Pharmaceuticals | | | Zomedica Pharmaceuticals History | | | Zomedica Pharmaceuticals Valuation | Previous | Next |
Zomedica Pharmaceuticals Trading Date Momentum on October 14, 2024
| On October 15 2024 Zomedica Pharmaceuticals Corp was traded for 0.12 at the closing time. Highest Zomedica Pharmaceuticals's price during the trading hours was 0.13 and the lowest price during the day was 0.12 . The net volume was 5.9 M. The overall trading history on the 15th of October 2024 contributed to the next trading period price depreciation. The trading date delta to the next next day price was 7.69% . The trading date delta to current price is 7.69% . |
Zomedica Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Zomedica Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zomedica Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zomedica financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zomedica Pharmaceuticals Stock history
Zomedica Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zomedica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zomedica Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zomedica Pharmaceuticals stock prices may prove useful in developing a viable investing in Zomedica Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 979.9 M | 1 B | |
| Net Loss | -15.3 M | -16.1 M |
Zomedica Pharmaceuticals Quarterly Net Working Capital |
|
Zomedica Pharmaceuticals Stock Technical Analysis
Zomedica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Zomedica Pharmaceuticals Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Zomedica Pharmaceuticals Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zomedica Pharmaceuticals December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Zomedica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zomedica Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zomedica Pharmaceuticals stock market strength indicators, traders can identify Zomedica Pharmaceuticals Corp entry and exit signals to maximize returns
Zomedica Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zomedica Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Zomedica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zomedica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0231 | |||
| Jensen Alpha | 0.0286 | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.2172 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share 0.027 | Quarterly Revenue Growth 0.018 | Return On Assets (0.09) | Return On Equity (0.24) |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.